1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEWAMSTERDAM PHARMA COMPANY NV
NewAmsterdam Pharma Company NV XNAS: NAMS

NewAmsterdam Pharma Company NV Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, i...

Read More
24.05 0.10 (0.42%)
71.05% Gain from 52W Low
812.0K
XNAS Volume

XNAS 29 Aug, 2025 4:01 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
10.0 / 100
Momentum Score
Technically Neutral
53.9 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
40
1Yr Price target upside is 67%
11 analysts

15

S

7

W

5

O

0

T

SWOT Analysis

NewAmsterdam Pharma Compan... Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..